Cash Flow Statement
Growth Metrics

Harvard Bioscience (HBIO) Long-Term Deferred Tax (2016 - 2019)

Harvard Bioscience (HBIO) has disclosed Long-Term Deferred Tax for 10 consecutive years, with $210000.0 as the latest value for Q2 2019.

  • Quarterly Long-Term Deferred Tax rose 18.64% to $210000.0 in Q2 2019 from the year-ago period, while the trailing twelve-month figure was $210000.0 through Jun 2019, up 18.64% year-over-year, with the annual reading at $182000.0 for FY2017, 84.27% down from the prior year.
  • Long-Term Deferred Tax for Q2 2019 was $210000.0 at Harvard Bioscience, up from $208000.0 in the prior quarter.
  • The five-year high for Long-Term Deferred Tax was $11.0 million in Q3 2015, with the low at $177000.0 in Q2 2018.
  • Average Long-Term Deferred Tax over 5 years is $2.6 million, with a median of $1.0 million recorded in 2016.
  • The sharpest move saw Long-Term Deferred Tax crashed 91.57% in 2016, then surged 36.73% in 2017.
  • Over 5 years, Long-Term Deferred Tax stood at $995000.0 in 2015, then rose by 16.28% to $1.2 million in 2016, then tumbled by 84.27% to $182000.0 in 2017, then dropped by 1.65% to $179000.0 in 2018, then increased by 17.32% to $210000.0 in 2019.
  • According to Business Quant data, Long-Term Deferred Tax over the past three periods came in at $210000.0, $208000.0, and $179000.0 for Q2 2019, Q1 2019, and Q3 2018 respectively.